COP vs PHAT · P/E 19, rev $58.94B vs rev $55.3M
ConocoPhillips (COP) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the COP and PHAT stock pages for the full models.
Not investment advice.